The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1754
May 11, 2026
View Complete Issue         Table of Contents 2019 
Leucovorin for Cerebral Folate Deficiency
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Leucovorin for Cerebral Folate Deficiency
May 11, 2026 (Issue: 1754)
The FDA has approved use of oral leucovorin calcium (folinic acid) for treatment of cerebral folate transport deficiency in patients who have a confirmed variant in the folate receptor 1 gene (FOLR1-CFTD). It is the first drug to be approved for...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Leucovorin for Cerebral Folate Deficiency
Article code: 1754b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.